| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20009981 | HPV | ENSG00000006283.18 | protein_coding | CACNA1G | No | No | 8913 | O43497 |
| TVIS44042288 | HTLV-1 | ENSG00000006283.18 | protein_coding | CACNA1G | No | No | 8913 | O43497 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNA1G |
|---|---|
| DrugBank ID | DB01115 |
| Drug Name | Nifedipine |
| Target ID | BE0008716 |
| UniProt ID | Q9P0X4 |
| Regulation Type | inhibitor |
| PubMed IDs | 16899990; 28611661 |
| Citations | Lee TS, Kaku T, Takebayashi S, Uchino T, Miyamoto S, Hadama T, Perez-Reyes E, Ono K: Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms. Pharmacology. 2006;78(1):11-20. Epub 2006 Aug 7.@@Godfraind T: Discovery and Development of Calcium Channel Blockers. Front Pharmacol. 2017 May 29;8:286. doi: 10.3389/fphar.2017.00286. eCollection 2017. |
| Groups | Approved |
| Direct Classification | Dihydropyridinecarboxylic acids and derivatives |
| SMILES | COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC |
| Pathways | Nifedipine Action Pathway |
| PharmGKB | PA450631 |
| ChEMBL | CHEMBL193 |
